Susan Alpert, SFA Consulting, Global Regulatory Strategy

Practical Advice for Your Regulatory Strategy

By MedTech Intelligence Staff
No Comments
Susan Alpert, SFA Consulting, Global Regulatory Strategy

For companies in global markets, consider these three factors.

“The regulatory strategy is [part of] the corporate strategy, because without us, they can’t market in any geography,” said Susan Alpert, principal at SFA Consulting during a recent conference organized by MedTech Intelligence. In the following video, Alpert offers three key points companies should consider when building a global regulatory strategy: Go where the patients are, plan for critical markets, and know the regulatory timing based on the geography in which you’re seeking to market your product.

About The Author

MedTech Intelligence

Leave a Reply

Your email address will not be published. Required fields are marked *